Previous 10 | Next 10 |
Shares of Accolade, Inc. (NASDAQ: ACCD) traded at a new 52-week high today and are currently trading at $16.56. So far today, approximately 272k shares have been exchanged, as compared to an average 30-day volume of 462.6k shares. Accolade, Inc. develops and provides technology-enabled soluti...
SEATTLE, April 24, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves millions of members, today announced that it will host an Analyst Day at the Wynn Las Vegas on May 8, 2023 and will provide a webcast of the event beginning at 1pm PT. Members o...
Shares of Accolade, Inc. (NASDAQ: ACCD) traded at a new 52-week high today and are currently trading at $14.72. So far today, approximately 192.23k shares have been exchanged, as compared to an average 30-day volume of 501.17k shares. Accolade, Inc. develops and provides technology-enabled so...
SEATTLE, April 11, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves millions of members, today announced that it will release fiscal fourth quarter 2023 financial results on Thursday, April 27, 2023, after the market closes. In conjunction, the compan...
2023-04-04 17:08:18 ET Gainers: Roivant Sciences ( ROIV ) +5% . Leonardo DRS ( DRS ) +4% . Kura Sushi USA ( KRUS ) +4% . SomaLogic ( SLGC ) +4% . Accolade ( ACCD ) +4% . Losers: Verona Pharma ( VRNA ) -4...
2023-03-23 10:59:18 ET Shares of IT-led healthcare services company Accolade ( NASDAQ: ACCD ) added ~13% on Thursday to reach an 11-month high after Guggenheim upgraded it to Buy from Neutral, citing an improved profitability outlook. The analyst Sandy Draper said that...
Accolade Welcomes Lyra Health to Its Trusted Partner Ecosystem PR Newswire Accolade and Lyra will offer employers purpose-built integrations that help address barriers to behavioral health care SEATTLE , March 6, 2023 /PRNewswire/ -- Accolade, Inc. (Nasda...
SEATTLE, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced changes to its Board of Directors. The Company announced today that long-time executive Michael Hilton will step down from his operating role at the Company to join the Board of Directors, replacing Tom Neff,...
Blue Shield of California Launches Virtual Blue Benefit Plan Incorporating Primary, Mental Health, and Specialty Care PR Newswire The nonprofit health plan teams up with Accolade and TeleMed2U to connect members to virtual and in-person care through a new, virtual-first plan. ...
Summary ARK Invest’s 13F portfolio value decreased from $14.35B to $11.54B this quarter. They increased Tesla, Ginkgo Bioworks, and Coinbase Global stakes while decreasing NVIDIA, Fate Therapeutics, and TuSimple Holdings during the quarter. The top three positions are Exact S...
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, NY / ACCESSWIRE / July 15, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD). Investors who purchased Accolade securities are encouraged to obtain additional information ...
NEW YORK, NY / ACCESSWIRE / July 11, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD). Investors who purchased Accolade securities are encouraged to obtain additional information ...
A look at the top 10 most actives in the United States Innovative Eyewear Inc. (LUCY) rose 50.0% to $0.495 on volume of 360,218,139 shares NVIDIA Corporation (NVDA) fell 0.4% to $123.54 on volume of 307,578,749 shares Ginkgo Bioworks Holdings Inc. Class A (DNA) rose 8.1% to $0.3343 on vol...